Aims: The extent to which the location of micrometastases (MIC) or isolated tumor cells (ITC) in sentinel lymph nodes (SLNs) is correlated with the risk of downstream metastases is still unknown. This study examined this issue and compared the impact of MIC/ITC location with other established risk factors.
Methods: Paraffin slides of SLNs with MIC/ITC-involvement obtained from 68 breast cancer patients were evaluated for MIC/ITC location, lesion size, and various SLN morphologic features. These parameters, together with demographic data and primary tumor characteristics, were analyzed using univariate and multivariate analysis to determine their association with the presence of downstream macrometastases in Non-SLN.
Results: Eighteen of 68 patients with MIC (n=37) or ITC (n=31) had Non-SLN metastases. After multivariate analysis, the location of MIC/ITC in the SLN (parenchyma vs. sinus/vessel) had the strongest association with the presence of Non-SLN macrometastases (p<0.0001), followed by the pT-category (p=0.008). Sixteen of 18 patients with parenchymal involvement but only 2 of 31 without parenchymal involvement had Non-SLN macrometastases. The metric size of the primary tumor and the estrogen receptor status were significantly associated only on univariate analysis (p=0.041, 0.034), whereas the correlation to the size classification for tumor cell deposits (MIC vs. ITC) was not significant (p=0.077).
Conclusions: The results indicate that lesion location is an important predictor of Non-SLN-macrometastases. This finding may simplify the decision for axillary treatment in patients with small tumor deposits in the SLN.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejso.2007.07.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Micrometastases in axillary lymph nodes in breast cancer, post-neoadjuvant systemic therapy.
Breast Cancer Res
July 2024
Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Article Synopsis
- The study investigates the role of micrometastases in axillary lymph nodes after neoadjuvant systemic therapy (NST) in breast cancer patients, aiming to understand their impact on prognosis.
- Among 978 analyzed patients, 9.1% had micrometastases, showing a higher prevalence of additional metastases compared to those without node involvement.
- The findings suggest that while micrometastases do not affect recurrence-free survival, they are linked to worse outcomes, indicating that further axillary lymph node dissection may be necessary for affected patients.
Feasibility and Diagnostic Accuracy of Ultrastaging in the Detection of Micrometastases in Sentinel and Non-sentinel Lymph Nodes in Cervical Cancer: A Single-Center Retrospective Study With a Five-Year Follow-Up Period.
Cureus
May 2024
Department of Obstetrics and Gynecology, Victor Babes University of Medicine and Pharmacy, Timisoara, ROU.
Background: Cervical cancer is the fourth most common cause of malignant tumor-related deaths among women in developing nations. Cervical cancer has been estimated to cause 527.600 new cases and 265.
View Article and Find Full Text PDFBetween Pathological Prostate Cancer Lymph Nodes and Sentinel Nodes: Which Information Is the Leader?
Clin Nucl Med
November 2024
From the Institut de Cancérologie de l'Ouest, F-44000, Saint-Herblain, France.
Article Synopsis
- This study evaluated the clinical outcomes of localized prostate cancer patients undergoing radical laparoscopic prostatectomy with sentinel lymph node biopsy (SLNB) and pelvic lymph node dissection, focusing on recurrence-free survival (RFS).* -
- Out of 231 patients studied, 16.5% were found to have positive sentinel lymph nodes, with significant implications for their prognosis, suggesting that knowing the status of SLNs is crucial for patient management.* -
- The findings indicated that RFS is significantly higher in patients with negative SLNs compared to those with positive SLNs, highlighting the importance of SLNB in predicting clinical outcomes in intermediate- and high-risk prostate cancer.*
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma.
World J Surg Oncol
April 2024
Department of Surgical Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
Background: Some studies have suggested that axillary lymph node dissection (ALND) can be avoided in women with cN0 breast cancer with 1-2 positive sentinel nodes (SLNs). However, these studies included only a few patients with invasive lobular carcinoma (ILC), so the validity of omitting ALDN in these patients remains controversial. This study compared the frequency of non-sentinel lymph nodes (non-SLNs) metastases in ILC and invasive ductal carcinoma (IDC).
View Article and Find Full Text PDFIncidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study.
Int J Gynecol Cancer
May 2024
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, USA
Objective: Ultrastaging is accurate in detecting nodal metastases, but increases costs and may not be necessary in certain low-risk subgroups. In this study we examined the risk of nodal involvement detected by sentinel lymph node (SLN) biopsy in a large population of apparent early-stage endometrial cancer and stratified by histopathologic characteristics. Furthermore, we aimed to identify a subgroup in which ultrastaging may be omitted.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!